Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 73

1.

Comparative effectiveness of low-molecular-weight heparin versus unfractionated heparin for thromboembolism prophylaxis for medical patients.

Rothberg MB, Pekow PS, Lahti M, Lindenauer PK.

J Hosp Med. 2012 Jul-Aug;7(6):457-63. doi: 10.1002/jhm.1938. Epub 2012 Apr 2.

PMID:
22473716
2.

Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients.

Kanaan AO, Silva MA, Donovan JL, Roy T, Al-Homsi AS.

Clin Ther. 2007 Nov;29(11):2395-405. Review.

PMID:
18158080
3.

Subcutaneous unfractionated heparin for the initial treatment of venous thromboembolism.

Robertson L, Strachan J.

Cochrane Database Syst Rev. 2017 Feb 14;2:CD006771. doi: 10.1002/14651858.CD006771.pub3. Review.

PMID:
28195640
4.

Bleeding risk during treatment of acute thrombotic events with subcutaneous LMWH compared to intravenous unfractionated heparin; a systematic review.

Costantino G, Ceriani E, Rusconi AM, Podda GM, Montano N, Duca P, Cattaneo M, Casazza G.

PLoS One. 2012;7(9):e44553. doi: 10.1371/journal.pone.0044553. Epub 2012 Sep 11. Review.

5.

Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for the initial treatment of venous thromboembolism.

Robertson L, Jones LE.

Cochrane Database Syst Rev. 2017 Feb 9;2:CD001100. doi: 10.1002/14651858.CD001100.pub4. Review.

PMID:
28182249
6.

International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer.

Farge D, Debourdeau P, Beckers M, Baglin C, Bauersachs RM, Brenner B, Brilhante D, Falanga A, Gerotzafias GT, Haim N, Kakkar AK, Khorana AA, Lecumberri R, Mandala M, Marty M, Monreal M, Mousa SA, Noble S, Pabinger I, Prandoni P, Prins MH, Qari MH, Streiff MB, Syrigos K, Bounameaux H, Büller HR.

J Thromb Haemost. 2013 Jan;11(1):56-70. doi: 10.1111/jth.12070. Review.

7.

Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism.

van Dongen CJ, van den Belt AG, Prins MH, Lensing AW.

Cochrane Database Syst Rev. 2004 Oct 18;(4):CD001100. Review. Update in: Cochrane Database Syst Rev. 2010;(9):CD001100.

PMID:
15495007
8.

Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy.

Di Nisio M, Porreca E, Ferrante N, Otten HM, Cuccurullo F, Rutjes AW.

Cochrane Database Syst Rev. 2012 Feb 15;(2):CD008500. doi: 10.1002/14651858.CD008500.pub2. Review. Update in: Cochrane Database Syst Rev. 2014;(8):CD008500.

9.

Unfractionated heparin versus low molecular weight heparin for avoiding heparin-induced thrombocytopenia in postoperative patients.

Junqueira DR, Perini E, Penholati RR, Carvalho MG.

Cochrane Database Syst Rev. 2012 Sep 12;(9):CD007557. doi: 10.1002/14651858.CD007557.pub2. Review. Update in: Cochrane Database Syst Rev. 2017 Apr 21;4:CD007557.

PMID:
22972111
10.

Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer.

Akl EA, Vasireddi SR, Gunukula S, Barba M, Sperati F, Terrenato I, Muti P, Schünemann H.

Cochrane Database Syst Rev. 2011 Jun 15;(6):CD006649. doi: 10.1002/14651858.CD006649.pub5. Review. Update in: Cochrane Database Syst Rev. 2014;6:CD006649.

PMID:
21678360
11.

Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer.

Akl EA, Vasireddi SR, Gunukula S, Barba M, Sperati F, Terrenato I, Muti P, Schünemann H.

Cochrane Database Syst Rev. 2011 Apr 13;(4):CD006649. doi: 10.1002/14651858.CD006649.pub4. Review. Update in: Cochrane Database Syst Rev. 2011;(6):CD006649.

PMID:
21491395
12.

Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer.

Akl EA, Rohilla S, Barba M, Sperati F, Terrenato I, Muti P, Schünemann HJ.

Cochrane Database Syst Rev. 2008 Jan 23;(1):CD006649. doi: 10.1002/14651858.CD006649.pub2. Review. Update in: Cochrane Database Syst Rev. 2011;(2):CD006649.

PMID:
18254108
13.

Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism.

Erkens PM, Prins MH.

Cochrane Database Syst Rev. 2010 Sep 8;(9):CD001100. doi: 10.1002/14651858.CD001100.pub3. Review. Update in: Cochrane Database Syst Rev. 2017 Feb 09;2:CD001100.

PMID:
20824828
14.

Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer.

Akl EA, Kahale L, Neumann I, Barba M, Sperati F, Terrenato I, Muti P, Schünemann H.

Cochrane Database Syst Rev. 2014 Jun 19;(6):CD006649. doi: 10.1002/14651858.CD006649.pub6. Review. Update in: Cochrane Database Syst Rev. 2018 Jan 24;1:CD006649.

PMID:
24945634
15.

Use of antithrombotic agents during pregnancy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

Bates SM, Greer IA, Hirsh J, Ginsberg JS.

Chest. 2004 Sep;126(3 Suppl):627S-644S. Review.

PMID:
15383488
16.

Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer.

Akl EA, Vasireddi SR, Gunukula S, Barba M, Sperati F, Terrenato I, Muti P, Schünemann H.

Cochrane Database Syst Rev. 2011 Feb 16;(2):CD006649. doi: 10.1002/14651858.CD006649.pub3. Review. Update in: Cochrane Database Syst Rev. 2011;(4):CD006649.

PMID:
21328285
17.

Comparative effectiveness of low-molecular-weight heparins versus other anticoagulants in major orthopedic surgery: a systematic review and meta-analysis.

Sobieraj DM, Coleman CI, Tongbram V, Chen W, Colby J, Lee S, Kluger J, Makanji S, Ashaye A, White CM.

Pharmacotherapy. 2012 Sep;32(9):799-808. doi: 10.1002/j.1875-9114.2012.01106.x. Epub 2012 Jun 28. Review.

PMID:
22744711
18.

Unfractionated or low-molecular weight heparin for induction of remission in ulcerative colitis.

Chande N, McDonald JW, Macdonald JK.

Cochrane Database Syst Rev. 2008 Apr 16;(2):CD006774. doi: 10.1002/14651858.CD006774.pub2. Review. Update in: Cochrane Database Syst Rev. 2010;(10):CD006774.

PMID:
18425969
19.

Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery.

Rasmussen MS, Jørgensen LN, Wille-Jørgensen P.

Cochrane Database Syst Rev. 2009 Jan 21;(1):CD004318. doi: 10.1002/14651858.CD004318.pub2. Review.

PMID:
19160234
20.

Venous thromboembolism prophylaxis with unfractionated heparin in the hospitalized medical patient: the case for thrice daily over twice daily dosing.

Mahan CE, Pini M, Spyropoulos AC.

Intern Emerg Med. 2010 Aug;5(4):299-306. doi: 10.1007/s11739-010-0359-8. Epub 2010 Feb 23. Review.

PMID:
20177819

Supplemental Content

Support Center